Sandhoff Disease Market Insights — Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the development
Sandhoff disease is an inherited lipid storage disorder that continuously destroys nerve cells in the brain and the spinal cord. Sandhoff disease is caused by a deficiency of the enzymes beta-hexosaminidase, which causes harmful accumulation of certain fats (lipids) in the brain and the other body organs.
People who are affected by Sandhoff’s disease don’t have enough enzymes in their bod called beta-hexosaminidase. Due to the lack of this enzyme, too much fat (lipid) builds up in the cells. The excess of this fat in the body causes damage to the brain and the other parts of the body, which can lead to death in early childhood.
DelveInsight’s “Sandhoff Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Sandhoff Disease, historical and forecasted epidemiology as well as the Sandhoff Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Sandhoff Disease Market Report:
- Sandhoff disease is a rare disorder that affects around 1 in 1,000,000 individuals
- Sandhoff’s illness was first discovered in Germany in 1965 by Drs. Horst Jatzkewitz, Hartmut Pilz, and Konrad Sandhoff
- The prevalence of Sandhoff disease is most common in Northern Argentina and Canada
Request a sample for the Report: https://www.delveinsight.com/sample-request/sandhoff-disease-market
The symptoms of Sandhoff disease include –
- Abnormal bone development
- Awkward movements
- Red spots in the eyeballs
- Enlarged head
- Enlarged internal body organs
Sandhoff Disease Market
The dynamics of the Sandhoff Disease market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as IB1001, Zavesca, and others during the forecasted period 2019–2032.
Learn more by requesting for sample @Sandhoff Disease Market Landscape
- venglustat GZ402671
- IntraBio Inc
- Idorsia Pharmaceuticals
Click here to read more about Sandhoff Disease Market Outlook 2032
Sandhoff Disease Pipeline
“Sandhoff Disease Pipeline Insight, 2022” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Sandhoff Disease market. A detailed picture of the Sandhoff Disease pipeline landscape is provided, which includes the disease overview and Sandhoff Disease treatment guidelines.
Diagnostic Imaging Equipment Market
Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.
Invasive Candidiasis Market
“DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.
DelveInsight’s “Sialidosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Filgrastim Biosimilar Insight
DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Pain Management Devices Market
Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027.
Latest Reports by DelveInsight
Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market
For more detailed information about the EULAR conference visit: https://www.delveinsight.com/eular-conference/eular-2022
To know more about our Competitive Services, Click here: Pharma Competitive Intelligence
Also, take a glance at the Blogs by DelveInsight: